Search alternatives:
point decrease » point increase (Expand Search)
ms decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
b decrease » a decrease (Expand Search), b1 decreased (Expand Search), _ decreased (Expand Search)
16 b » 16 _ (Expand Search), 1 b (Expand Search), 6 b (Expand Search)
point decrease » point increase (Expand Search)
ms decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
b decrease » a decrease (Expand Search), b1 decreased (Expand Search), _ decreased (Expand Search)
16 b » 16 _ (Expand Search), 1 b (Expand Search), 6 b (Expand Search)
-
1
-
2
DART-ID decreases missing datapoints across runs.
Published 2019“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”
-
3
-
4
-
5
-
6
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Elevated PE level in yeast decreases the sensitivity of replicating tombusvirus RNA to the reconstituted RNAi.
Published 2017“…<p>(A-B) Induction of RNAi in <i>cho2Δ</i> yeast inhibits TBSV repRNA accumulation less effectively than in wt yeast. …”
-
15
-
16
-
17
-
18
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
19
-
20